Collectively, these findings suggest that upregulated tumorous SQLE expression correlates with poor clinical outcome, and reduced CD8+ T cell infiltration and activation, highlighting SQLE as a potential modulator of the TME in HCC. Here, CD8A is linked to hepatocellular carcinoma.